TCL Archive Deflecting Earmarks, NCI Advisors Lay Out Research Opportunities In Breast, Prostate February 26, 1999
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned September 7, 2012
TCL Archive Stereotactic Radiosurgery Improves Survival Without Whole-Brain Radiotherapy September 27, 2013
